Skip to main content
Kathryn Arbour, MD, Oncology, New York, NY

KathrynCeciliaArbourMD

Oncology • New York, NY

Hematologic Oncology, Thoracic Cancer

Assistant Attending Thoracic Oncology Service Memorial Sloan Kettering Cancer Center

Request Appointment

Overview of Dr. Arbour

Dr. Kathryn Arbour is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 6 years. She is one of 494 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 40 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2017
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Chief Residency, Internal Medicine, 2014 - 2015
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2013 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers  
    G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology

Lectures

  • ml-RECIST: Machine learning to estimate RECIST in patients with NSCLC treated with PD-(L)1 blockade. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Drs. Kathryn Arbour, Carl Gay, and Sean Pitroda Receive Prestigious LUNGevity 2020 Career Development Awards
    Drs. Kathryn Arbour, Carl Gay, and Sean Pitroda Receive Prestigious LUNGevity 2020 Career Development AwardsSeptember 11th, 2020
  • Kathryn Arbour, MD, on the Development of KRAS G12C Inhibitors in Lung Cancer
    Kathryn Arbour, MD, on the Development of KRAS G12C Inhibitors in Lung CancerNovember 19th, 2019
  • Corticosteroid Use at Start of PD-1/PD-L1 Inhibitor Therapy Affects Outcomes in NSCLC
    Corticosteroid Use at Start of PD-1/PD-L1 Inhibitor Therapy Affects Outcomes in NSCLCNovember 10th, 2018
  • Join now to see all

Dr. Kathryn Arbour, Dr. Kathryn Arbour, MD, Dr. K Arbour, Dr. Kathryn Cecilia Arbour